ProCE Banner Activity

An Expert’s Guide to Key Studies at the 2024 ASCO Genitourinary Cancers Symposium

Conference Coverage
Clinical Thought

Experts highlight key studies in prostate, bladder, and renal cancers being presented at the 2024 ASCO Genitourinary Cancers Symposium.

Released: January 24, 2024

Share

Faculty

Terence Friedlander

Terence Friedlander, MD

Professor of Medicine and Robert and Virginia O’Reilly Family Endowed Chair
Chief, Zuckerberg San Francsico General Hospital
Division of Hematology/Oncology
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California

Rana R. McKay

Rana R. McKay, MD

Associate Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
University of California, San Diego
Genitourinary Oncology Team Lead
Moores Cancer Center
La Jolla, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Exelixis, Inc., and Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

AstraZeneca

Exelixis, Inc.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Disclosure

Primary Author

Terence Friedlander, MD

Professor of Medicine and Robert and Virginia O’Reilly Family Endowed Chair
Chief, Zuckerberg San Francsico General Hospital
Division of Hematology/Oncology
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California

Terence Friedlander, MD: consultant/advisor/speaker: AADI Biosciences, Astellas, AstraZeneca, EMD Serono, Merck, Seagen.

Rana R. McKay, MD

Associate Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
University of California, San Diego
Genitourinary Oncology Team Lead
Moores Cancer Center
La Jolla, California

Rana R. McKay, MD: consultant/advisor/speaker: Ambrx, AstraZeneca, Aveo, Bayer, Blue Earth Diagnostics, Bristol Myers Squibb, Calithera, Caris, Dendreon, Esiai, Exelixis, Janssen, Lilly, Merck, Myovant, Novartis, Pfizer, Sanofi, SeaGen, Sorrento Therapeutics, Telix, Tempus; researcher (paid to institution): Artera, AstraZeneca, Bayer, Bristol Myers Squibb, Exelixis, Oncternal, Tempus.